Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Babuty

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Optics Express|May 26, 2009
A semiconductor laser device for the generation of surface-plasmons upon electrical injectionA Bousseksou, R Colombelli, A Babuty, et al.
Physical Review Letters|September 28, 2010
Semiconductor surface plasmon sourcesA Babuty, A Bousseksou, J-P Tetienne, et al.
Optics Express|June 21, 2012
Sub-wavelength energy concentration with electrically generated mid-infrared surface plasmonsA Bousseksou, A Babuty, J-P Tetienne, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Optics Express|May 26, 2009
A semiconductor laser device for the generation of surface-plasmons upon electrical injectionA Bousseksou, R Colombelli, A Babuty, et al.
Physical Review Letters|September 28, 2010
Semiconductor surface plasmon sourcesA Babuty, A Bousseksou, J-P Tetienne, et al.
Optics Express|June 21, 2012
Sub-wavelength energy concentration with electrically generated mid-infrared surface plasmonsA Bousseksou, A Babuty, J-P Tetienne, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Pageof 1